[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:scn2a-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"SCN2A Gene",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05737784","A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-03T02:22:29.706078Z","2026-05-05T02:43:27.317514Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07019922","A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety",[19],"Phase 3","2026-08-26T02:19:23.493898Z","2026-05-05T02:43:27.285907Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06585605","A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes",[],"2026-08-26T02:17:50.500039Z","2026-06-02T11:21:24.705937Z"]